2-(4-溴苯基)-N-甲基乙胺 | 725683-06-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-(4-溴苯基)-N-甲基乙胺
• 中文别名: 4-溴-N-甲基苯乙胺
• 英文名称: 2-(4-bromophenyl)-N-methylethan-1-amine
• 英文别名: [2-(4-bromophenyl)ethyl]methylamine；2-(4-bromophenyl)-N-methylethanamine
• CAS: 725683-06-7
• 化学式: C₉H₁₂BrN
• mdl: MFCD06738718
• 分子量: 214.105
• InChiKey: CJLDHHONSQXJTC-UHFFFAOYSA-N

物化性质

• 沸点：
  264.8±15.0 °C(Predicted)
• 密度：
  1.307±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  11
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.333
• 拓扑面积：
  12
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 海关编码：
  2921499090

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2-(4-Bromophenyl)-N-methylethanamine
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 2-(4-Bromophenyl)-N-methylethanamine
CAS number: 725683-06-7

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C9H12BrN
Molecular weight: 214.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-(4-溴苯基)-N-甲基乙胺 在 1,10-菲罗啉 、 iron(II) chloride tetrahydrate 、 sodium carbonate 、 三乙胺 、 N,N'-二环己基碳二亚胺 作用下， 以 四氢呋喃 、 二氯甲烷 、 乙腈 为溶剂， 反应 50.0h， 生成 4-(4-bromophenyl)-1-methylimidazolidin-2-one
  参考文献：
  名称：

  使用简单的铁-菲咯啉催化剂对活化和非活化的 C(sp3)−H 键进行有效胺化

  摘要：

  由二氯化铁与 1,10-菲咯啉组合组成的现成催化剂可催化N-苯甲酰氧基脲的闭环 C-H 胺化，以高产率形成咪唑烷-2-酮。C−H 胺化反应非常普遍，适用于苯甲基、烯丙基、炔丙基和完全非活化的脂肪族 C(sp 3 )−H 键，并且也适用于 C(sp 2 )−H 键。这种令人惊讶的简单方法可以在敞口烧瓶条件下进行。

  DOI：

  10.1002/anie.202013687
• 作为产物：
  描述：

  2-(4-溴苯基)-N-甲基乙酰胺 在 硼烷四氢呋喃络合物 作用下， 以 四氢呋喃 为溶剂， 反应 4.0h， 生成 2-(4-溴苯基)-N-甲基乙胺
  参考文献：
  名称：

  铁催化的N-苯甲酰氧基脲分子内CH-酰胺化反应

  摘要：

  描述了N-苯甲酰氧基脲的氧化还原中性铁催化的分子内CH酰胺化。该方法采用的是由Fe（OTf）2和联吡啶作为催化剂而原位生成的简单铁络合物，而作为氮烯前体的N-苯甲酰氧基脲则不使用外源氧化剂。通过脂族C（sp 3）-H酰胺化以优异的产率合成了一系列环状脲。另外，该催化体系也适合芳基C（sp 2）-H亚硝基插入，以中等产率提供苯并咪唑酮。

  DOI：

  10.1002/cjoc.202100005

文献信息

• [EN] COMPOUNDS, PREPARATIONS AND USES THEREOF<br/>[FR] COMPOSÉS, LEURS PRÉPARATIONS ET LEURS UTILISATIONS
  申请人：PETER MACCALLUM CANCER INST

  公开号：WO2011075784A1

  公开（公告）日：2011-06-30

  The present invention provides novel compounds of the Formula (I), pharmaceutical compositions comprising such compounds and methods for using such compounds as agents or drugs for inhibiting perforin activity and for treating a subject at risk of or susceptible to a disease or disorder, or having a disease or disorder associated with undesirable perforin activity.

  本发明提供了式（I）的新化合物，包括这些化合物的药物组合物以及使用这些化合物作为抑制穿孔素活性的药剂或药物，用于治疗患有与不良穿孔素活性相关的疾病或紊乱、或处于患有风险或易感染某种疾病或紊乱的受试者的方法。
• USE OF ARYL CARBAMATES IN AGRICULTURE AND OTHER PLANT-RELATED AREAS
  申请人：North Carolina State University

  公开号：US20130172187A1

  公开（公告）日：2013-07-04

  Disclosure is provided for methods of preventing, removing or inhibiting microbial biofilm formation or microbial infection in a plant or plant part thereof, including applying thereto a treatment effective amount of an aryl carbamate as described herein, or an agriculturally acceptable salt thereof. Methods of enhancing a microbicide (e.g., including a copper, antibiotic, bacteriophage, etc.) and/or plant defense activator are also provided, including applying an active compound as described herein. Compositions comprising an aryl carbamate compound as described herein in an agriculturally acceptable carrier are also provided, and in some embodiments the compositions further include a microbicide (e.g., including copper, antibiotic, bacteriophage, etc.) and/or a plant defense activator.

  本公开提供了一种防止、去除或抑制植物或其部分中微生物生物膜形成或微生物感染的方法，包括向其施加本文所述的芳基氨基甲酸酯或其农业可接受的盐的治疗有效量。还提供了增强微生物杀灭剂（例如，包括铜、抗生素、噬菌体等）和/或植物防御激活剂的方法，包括施加本文所述的活性化合物。还提供了包含本文所述的芳基氨基甲酸酯化合物的组合物，其在农业上可接受的载体中，并且在某些实施例中，这些组合物进一步包括微生物杀灭剂（例如，包括铜、抗生素、噬菌体等）和/或植物防御激活剂。
• Antitumor Agent
  申请人：Arai Hitoshi

  公开号：US20090012060A1

  公开（公告）日：2009-01-08

  The present invention provides an antitumor agent and the like, which comprises as an active ingredient, a pyrimidine derivative represented by Formula (I): [wherein —X—Y-Z- represents —O—CR 3 ═N— (wherein R 3 represents a hydrogen atom, a substituted or unsubstituted aromatic heterocyclic group and the like) and the like, R 1 represents —NR 10 R 11 (wherein R 10 and R 11 may be the same or different, and each represents a hydrogen atom, substituted or unsubstituted lower alkyl and the like) and the like, R 2 represents —NR 13 R 14 (wherein R 13 and R 14 may be the same or different, and each represents a hydrogen atom, substituted or unsubstituted lower alkyl and the like)] or a pharmaceutically acceptable salt thereof.

  本发明提供了一种抗肿瘤剂及类似物，其包括一种以嘧啶衍生物为活性成分，其表示为式（I）：[其中- X-Y-Z-表示-O-CR3═N-（其中R3表示氢原子，取代或未取代的芳香族杂环基等），R1表示-NR10R11（其中R10和R11可以相同或不同，且每个表示氢原子，取代或未取代的较低烷基等），R2表示-NR13R14（其中R13和R14可以相同或不同，且每个表示氢原子，取代或未取代的较低烷基等）]或其药学上可接受的盐。
• MACROCYCLIC FACTOR VIIA INHIBITORS USEFUL AS ANTICOAGULANTS
  申请人：Priestley Eldon Scott

  公开号：US20090281139A1

  公开（公告）日：2009-11-12

  The present invention relates generally to novel macrocycles of Formula (I): or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates, or prodrugs thereof, wherein the variables A, B, L, M, W, Z, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , and R 10 are as defined herein. These compounds are selective inhibitors of the serine protease coagulation factor VIIa which can be used as medicaments.

  本发明涉及一般的新型大环化合物，其化学式为（I）或其立体异构体、互变异构体、药学上可接受的盐、溶剂化合物或前药，其中变量A、B、L、M、W、Z、R1、R2、R3、R4、R5、R6、R7、R8、R9和R10如本文中所定义。这些化合物是选择性抑制剂凝血因子VIIa的丝氨酸蛋白酶，可用作药物。
• Imidazolyl derivatives
  申请人：Thurieau Alain Christophe

  公开号：US20070299073A1

  公开（公告）日：2007-12-27

  The present invention is directed to imidazolyl derivatives of formula (I) where the substituents are defined in the specification, which are useful as agonist or antagonists of somatostatin receptors.

  本发明涉及式（I）的咪唑基衍生物，其中取代基在说明书中定义，它们可用作生长抑素受体的激动剂或拮抗剂。